337 The Discovery and Preclinical Characterization of CC-223, a Novel mTOR Kinase Inhibitor Under Clinical Investigation

Title
337 The Discovery and Preclinical Characterization of CC-223, a Novel mTOR Kinase Inhibitor Under Clinical Investigation
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 48, Issue -, Pages 103
Publisher
Elsevier BV
Online
2012-11-07
DOI
10.1016/s0959-8049(12)72135-4

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now